Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ TET3 Monoclonal Antibody (GT334)
Mouse Monoclonal Antibody
Supplier: Invitrogen™ MA527863
Description
Positive Control: flag-human TET3-transfected 293T cells Predicted Reactivity: Mouse (94%) Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
TET3, a member of the ten-eleven-translocation (TET) family of genes, is a methylcytosine dioxygenase that catalyzes the conversion of methylcytosine to 5-hydroxymethylcytosine and is most abundantly expressed in hematopoietic cells. Unlike the related TET2 protein, mutations in TET3 have not been observed in any myeloid malignancies. TET3 has been shown to be involved in the demethylation of zygotic DNA before the first mitosis and has been suggested to be involved in the epigenetic reprogramming of the zygotic paternal DNA following natural fertilization and may also contribute to somatic cell nuclear reprogramming during animal cloning.
Specifications
TET3 | |
Monoclonal | |
1 mg/mL | |
PBS with no preservative | |
O43151 | |
TET3 | |
Recombinant protein encompassing a sequence within the C-terminus region of human TET3. The exact sequence is proprietary. | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG2b |
Western Blot | |
GT334 | |
Unconjugated | |
TET3 | |
B430006D22Rik; BC037432; D230004J03Rik; hCG_40738; KIAA0401; Methylcytosine dioxygenase TET3; MGC22014; probable methylcytosine dioxygenase TET3; putative methylcytosine dioxygenase; Tet methylcytosine deoxygenase 3 isoform; tet methylcytosine dioxygenase 3; tet oncogene family member 3; Tet3 | |
Mouse | |
Protein G | |
RUO | |
200424 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction